Compare Orchid Chemicals with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs SHASUN PHARMA - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD SHASUN PHARMA ORCHID PHARMA LTD/
SHASUN PHARMA
 
P/E (TTM) x -0.4 123.9 - View Chart
P/BV x 0.1 8.5 1.4% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 ORCHID PHARMA LTD   SHASUN PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
SHASUN PHARMA
Mar-14
ORCHID PHARMA LTD/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs19494 205.9%   
Low Rs3546 76.8%   
Sales per share (Unadj.) Rs276.5214.2 129.1%  
Earnings per share (Unadj.) Rs-79.25.3 -1,484.5%  
Cash flow per share (Unadj.) Rs-43.515.8 -274.7%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs53.953.3 101.1%  
Shares outstanding (eoy) m70.4556.62 124.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.40.3 126.9%   
Avg P/E ratio x-1.413.1 -11.0%  
P/CF ratio (eoy) x-2.64.4 -59.6%  
Price / Book Value ratio x2.11.3 162.0%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m8,0673,958 203.8%   
No. of employees `0002.8NA-   
Total wages/salary Rs m2,5272,164 116.8%   
Avg. sales/employee Rs Th6,956.1NM-  
Avg. wages/employee Rs Th902.5NM-  
Avg. net profit/employee Rs Th-1,993.0NM-  
INCOME DATA
Net Sales Rs m19,47712,127 160.6%  
Other income Rs m407229 177.5%   
Total revenues Rs m19,88412,356 160.9%   
Gross profit Rs m1,1031,009 109.3%  
Depreciation Rs m2,519594 424.4%   
Interest Rs m5,227415 1,259.2%   
Profit before tax Rs m-6,236230 -2,714.9%   
Minority Interest Rs m200-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125-73 172.2%   
Profit after tax Rs m-5,580302 -1,847.0%  
Gross profit margin %5.78.3 68.0%  
Effective tax rate %2.0-31.7 -6.3%   
Net profit margin %-28.72.5 -1,150.0%  
BALANCE SHEET DATA
Current assets Rs m11,0146,884 160.0%   
Current liabilities Rs m32,0608,456 379.1%   
Net working cap to sales %-108.1-13.0 833.8%  
Current ratio x0.30.8 42.2%  
Inventory Days Days9562 154.0%  
Debtors Days Days34108 31.2%  
Net fixed assets Rs m29,4404,970 592.3%   
Share capital Rs m705113 621.8%   
"Free" reserves Rs m2,0432,875 71.0%   
Net worth Rs m3,8003,020 125.8%   
Long term debt Rs m9,0181,817 496.2%   
Total assets Rs m46,51013,347 348.5%  
Interest coverage x-0.21.6 -12.4%   
Debt to equity ratio x2.40.6 394.4%  
Sales to assets ratio x0.40.9 46.1%   
Return on assets %-0.85.4 -14.1%  
Return on equity %-146.910.0 -1,468.1%  
Return on capital %-3.713.3 -28.0%  
Exports to sales %37.946.4 81.7%   
Imports to sales %22.614.2 158.8%   
Exports (fob) Rs m7,3785,622 131.2%   
Imports (cif) Rs m4,4061,728 255.0%   
Fx inflow Rs m7,5135,843 128.6%   
Fx outflow Rs m5,6492,173 259.9%   
Net fx Rs m1,8653,669 50.8%   
CASH FLOW
From Operations Rs m1,682398 423.0%  
From Investments Rs m-9,860-1,635 603.1%  
From Financial Activity Rs m6,6441,309 507.7%  
Net Cashflow Rs m-1,53571 -2,155.9%  

Share Holding

Indian Promoters % 32.3 39.2 82.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 3.6 127.8%  
FIIs % 3.3 17.6 18.8%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 39.6 139.6%  
Shareholders   84,811 20,750 408.7%  
Pledged promoter(s) holding % 54.9 12.3 446.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  CADILA HEALTHCARE  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Crashes 1,203 Points; IT and Banking Stocks Witness Selling(Closing)

Indian share markets extended losses in the first trading session of FY21, as the number of coronavirus cases in the country continued to rise.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout...(The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS